arginine vasopressin has been researched along with naloxone in 112 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 48 (42.86) | 18.7374 |
1990's | 48 (42.86) | 18.2507 |
2000's | 12 (10.71) | 29.6817 |
2010's | 4 (3.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Firemark, HM; Weitzman, RE | 1 |
de Wied, D; van Ree, JM | 2 |
Kokot, F; Widera, W; Wiecek, A | 1 |
Grzeszczak, W; Kokot, F; Zukowska-Szczechowska, E | 1 |
Berrino, L; Lampa, E; Maione, S; Rossi, F; Vitagliano, S | 1 |
Dayanithi, G; Nordmann, JJ; Stuenkel, EL | 1 |
Bapna, JS; Ramaswamy, S; Shewade, DG; Tyagi, MG | 1 |
Landgraf, R; Neumann, I; Russell, JA | 1 |
Forsling, ML; Wells, T | 1 |
Chiodera, P; Coiro, V | 3 |
Ito, M; Kondo, K; Murase, T; Oiso, Y; Otake, K | 1 |
Kondo, K; Oiso, Y; Otake, K | 1 |
Landgraf, R; Neumann, I; Russell, JA; Wolff, B | 1 |
Hasser, EM; Schadt, JC | 1 |
Bedin, M; Fillion, C; Hugues, JN; Pointis, G; Tahri-Joutei, A | 1 |
Drüge, G; Lenz, HJ | 1 |
Garland, EJ; Zis, AP | 1 |
Ashton, N; Balment, RJ; Blackburn, TP | 1 |
Meij, BP; Mol, JA; Rijnberk, A | 1 |
Bower, M; Johnson, MR; Lightman, SL; Seckl, JR | 1 |
Clarke, IJ; Doughton, BW; Horton, RJ | 1 |
Fleshner, M; Thurston, CL; Watkins, LR | 1 |
Kroodsma, JM; Maigret, C; Pot, ML; Stevens, M; Van Wimersma Greidanus, TB | 1 |
Bianconi, L; Capretti, L; Castelli, A; Cavazzini, U; Chiodera, P; Coiro, V; Marcato, A; Speroni, G; Volpi, R | 1 |
Brown, MR; Lenz, HJ | 1 |
Hart, SL; Oluyomi, AO | 1 |
Ben-Jonathan, N; Hyde, JF | 1 |
Masotto, C; Negro-Vilar, A; Wisniewski, G | 1 |
Johnson, MR; Lightman, SL; Seckl, JR | 1 |
Heslop, KE; Mathias, CJ; May, CN; Whitehead, CJ | 1 |
Dunne, MJ; Haddock, JA; Lightman, SL; Seckl, JR | 1 |
de Vries, HW; Hellebrekers, LJ; Lagerweij, E; van Wimersma Greidanus, TB | 1 |
Bicknell, RJ; Brown, D; Chapman, C; Zhao, BG | 1 |
Bianconi, L; Castelli, A; Chiodera, P; d'Amato, L; Gnudi, A; Marchesi, C; Minelli, R; Muzzetto, P; Pioli, G; Volpi, R | 1 |
Bicknell, RJ; Chapman, C; Leng, G | 1 |
Falke, N; Martin, R | 1 |
Parrott, RF; Thornton, SN | 1 |
Hellebrekers, LJ; Mol, JA; van den Brom, WE | 1 |
Coghlan, JP; Congiu, M; Scoggins, BA; Tresham, JJ; Wang, XM | 1 |
Baver-Neff, BS; Cronenwett, JL; Grekin, RJ; Sheagren, JN | 1 |
Baranowska, B; Cantin, M; Genest, J; Gutkowska, J | 1 |
Coiro, V; Goodman, HM | 1 |
Cameron, V; Espiner, EA; MacFarlane, MR; Nicholls, MG | 1 |
Johnson, M; Lightman, SL; Seckl, JR; Shakespear, C | 1 |
Iwasaki, Y; Kondo, K; Oiso, Y; Takatsuki, K; Tomita, A | 1 |
Arai, H; Itoh, H; Morii, N; Mukoyama, M; Nakao, K; Saito, Y; Sakamoto, M; Shiono, S; Sugawara, A; Yamada, T | 2 |
Lightman, SL; Seckl, JR | 1 |
Ferrario, CM; Szilagyi, JE | 1 |
Hódi, K; Kovács, GL; Laczi, F; László, FA; Telegdy, G; Vecsernyés, M | 1 |
Chiodera, P; Coiro, V; d'Amato, L; Davoli, C; Delsignore, R; Gnudi, A; Volpi, R | 1 |
Carter, DA; Lightman, SL | 1 |
Hunt, MM; Wade, CE | 1 |
Emmert, SE; Hartman, RD; Rosella-Dampman, LM; Summy-Long, JY | 1 |
Carter, DA; Lightman, SL; Williams, TD | 1 |
Brown, MR; Hester, SE; Lenz, HJ | 1 |
Ishikawa, S; Schrier, RW | 1 |
Costa, E; Del Río, J; Naranjo, JR; Yang, HY | 1 |
Jones, RT; Joseph, MS; Keil, LC; Rowbotham, MC | 1 |
Brush, FR; DeVito, WJ | 1 |
Bloom, AL; Giddings, JC; Moffat, EH | 1 |
Aziz, LA; Forsling, ML | 1 |
Fyhrquist, F; Kivalo, I; Lehtinen, AM | 1 |
Becker, RA; Blask, DE; Champney, TH; Johnson, LY; Reiter, RJ; Vaughan, GM; Vaughan, MK | 1 |
Bannister, R; Forsling, M; Lightman, SL; Puritz, R; Wilcox, CS | 1 |
Berntson, GG; Berson, BS; Kirk, WT; Torello, MW; Zipf, W | 1 |
Chee, O; Keil, LC; Rosella-Dampman, LM; Summy-Long, JY | 1 |
Forsling, M; Langdon, N; Lightman, S; Todd, K | 1 |
Forsling, ML; Lightman, SL | 1 |
Forsling, ML; Langdon, N; Lightman, SL | 1 |
Crofton, JT; Rockhold, RW; Share, L | 1 |
Diana, JN; Dowell, RT; Houdi, AA | 1 |
Donald, RA; Ellis, MJ; Evans, MJ; Inder, WJ | 1 |
Alexander, SL; Irvine, CH | 1 |
Bicknell, RJ; Bowden, C; Brown, D; Chapman, C; Leng, G; Russell, JA | 1 |
Dohanics, J; Verbalis, JG | 1 |
Crosbie, GV; Grice, JE; Hockings, GI; Jackson, RV; Torpy, DJ; Walters, MM | 1 |
Donald, RA; Ellis, MJ; Evans, MJ; Hellemans, J; Inder, WJ; Livesey, JH | 1 |
Koekkoek-van den Herik, I; Maigret, C; Smelik, WF; Van de Heijning, BJ; van Wimersma Greidanus, TB | 1 |
Liard, JF | 1 |
Alfano, F; Caffarri, G; Caiazza, A; Capretti, L; Chiodera, P; Coiro, V; Maffei, ML; Pagani, D; Papadia, C; Volpi, R | 1 |
Chen, C; Gao, L; Jiang, NC; Liu, DC; Pan, Y | 1 |
Allevard, AM; Bedin, M; Fillion, C; Gharib, C; Huges, JN; Pointis, G; Tahri-Joutei, A | 1 |
Bocchi, R; Caffarri, G; Capretti, L; Chiodera, P; Coiro, V; Marcato, A; Rossi, G; Volpi, R | 1 |
Ding, H; Wang, C; Zhang, T; Zheng, X | 1 |
Arima, H; Iwasaki, Y; Kondo, K; Murase, T; Oiso, Y | 1 |
Soong, Y; Szeto, HH; Taylor, CC; Wu, D; Yee, JS | 2 |
Ferin, M; Shalts, E; Thornell, D; Xia-Zhang, L; Xiao, E | 1 |
Ehrenreich, H; Gefeller, O; Kaw, S; Poser, W; Rüther, E; Schilling, L; tom Dieck, K | 1 |
Almeida, OF; Deicke, J; Fischer, D; Gärtner, P; Hassan, AH; Hellbach, S | 1 |
Ikeda, Y; Ishibashi, Y; Nakagawa, Y; Teramoto, A; Yoshii, T | 1 |
Abe, I; Fujishima, M; Fukuhara, M; Matsumura, K | 1 |
Ahn, DK; Ju, JS; Kim, KH; Kwon, S; Park, JS | 1 |
Chen Zhu, B; Clapper, JA; Hough, CM; Lado-Abeal, J; Norman, RL; Syapin, PJ | 1 |
Arima, H; Ishizaki, S; Miura, Y; Murase, T; Oiso, Y; Sugimura, Y; Tachikawa, K; Usdin, TB | 1 |
Janecka, A; Zubrzycka, M | 1 |
Bendor, JT; Ho, A; Kreek, MJ; Schlussman, SD; Yuferov, V; Zhou, Y | 1 |
Lin, BC; Liu, WY; Song, CY; Yang, J | 1 |
Frithiof, R; Rundgren, M | 1 |
Chen, JM; Lin, BC; Liu, WY; Song, CY; Yang, J | 1 |
Casti, A; Cataldo, S; Chiodera, P; Coiro, V; Maffei, ML; Manfredi, G; Melani, A; Rubino, P; Saccani Jotti, G; Volta, E | 1 |
Lin, BC; Liu, WY; Wang, CH; Wang, G; Xu, H; Yang, J; Yang, Y | 1 |
Casti, A; Chiodera, P; Coiro, V; Maffei, ML; Melani, A; Rubino, P; Saccani-Jotti, G; Vacca, P; Volpi, R; Volta, E | 1 |
Chiodera, P; Coiro, V; Maffei, ML; Melani, A; Volpi, R; Volta, E | 1 |
Cao, Y; Qin, X; Yang, Y; Zhao, HY; Zhao, SF | 1 |
1 review(s) available for arginine vasopressin and naloxone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 trial(s) available for arginine vasopressin and naloxone
Article | Year |
---|---|
Effect of vasopressin and naloxone alone and in combination on cortisol secretion after dexamethasone pretreatment.
Topics: Adult; Arginine Vasopressin; Dexamethasone; Drug Combinations; Humans; Hydrocortisone; Male; Naloxone; Random Allocation | 1990 |
Vasopressin and oxytocin responses to hypertonic saline infusion: effect of the opioid antagonist naloxone.
Topics: Adult; Arginine Vasopressin; Blood Pressure; Heart Rate; Humans; Infusions, Intravenous; Male; Naloxone; Osmolar Concentration; Oxytocin; Saline Solution, Hypertonic; Thirst | 1989 |
Failure of naloxone to reverse apomorphine effects in humans.
Topics: Adolescent; Adult; Apomorphine; Arginine Vasopressin; Blood Pressure; Drug Interactions; Growth Hormone; Heart Rate; Humans; Male; Naloxone; Nausea; Prolactin; Receptors, Opioid | 1983 |
The effect of desamino-D-arginine vasopressin (DDAVP) and naloxone infusions on factor VIII and possible endothelial cell (EC) related activities.
Topics: Adolescent; Adult; Aged; Antigens; Antithrombin III; Arginine Vasopressin; Cells, Cultured; Child; Deamino Arginine Vasopressin; Endothelium; Factor VIII; Female; Hemophilia A; Humans; Male; Middle Aged; Naloxone; Plasminogen Activators; Umbilical Veins; von Willebrand Diseases; von Willebrand Factor | 1984 |
Naloxone increases the nicotine-stimulated rise of vasopressin secretion in man.
Topics: Adult; Arginine Vasopressin; Female; Humans; Male; Naloxone; Nicotine; Osmolar Concentration; Plasma; Urine | 1982 |
A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
Topics: Adrenocorticotropic Hormone; Adult; Arginine Vasopressin; Corticotropin-Releasing Hormone; Enzyme-Linked Immunosorbent Assay; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Insulin; Male; Middle Aged; Naloxone; Narcotic Antagonists; Pituitary-Adrenal System; Radioimmunoassay; Stimulation, Chemical | 1995 |
A synergistic adrenocorticotropin response to naloxone and vasopressin in normal humans: evidence that naloxone stimulates endogenous corticotropin-releasing hormone.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Arginine Vasopressin; Calcium; Corticotropin-Releasing Hormone; Drug Synergism; Female; Humans; Male; Middle Aged; Naloxone; Nifedipine; Reference Values; Single-Blind Method; Stimulation, Chemical | 1995 |
Sustained elevation of vasopressin plasma levels in healthy young men, but not in abstinent alcoholics, upon expectation of novelty.
Topics: Adult; Alcoholism; Arginine Vasopressin; Arousal; Circadian Rhythm; Corticotropin-Releasing Hormone; Double-Blind Method; Humans; Male; Middle Aged; Naloxone; Narcotic Antagonists; Reference Values; Temperance; Water-Electrolyte Balance | 1997 |
Naloxone decreases the inhibitory effect of ethanol on the release of arginine-vasopressin induced by physical exercise in man.
Topics: Adult; Arginine Vasopressin; Blood Pressure; Carbon Dioxide; Central Nervous System Depressants; Dose-Response Relationship, Drug; Ethanol; Exercise; Gene Expression Regulation; Heart Rate; Humans; Male; Naloxone; Narcotic Antagonists; Oxygen Consumption; Pulmonary Ventilation; Respiration; Tidal Volume; Time Factors; Young Adult | 2009 |
102 other study(ies) available for arginine vasopressin and naloxone
Article | Year |
---|---|
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effects of beta-endorphin, morphine and naloxone on arginine vasopressin secretion and the electroencephalogram.
Topics: Animals; Arginine Vasopressin; Cerebral Cortex; Dose-Response Relationship, Drug; Electroencephalography; Endorphins; Evoked Potentials; Injections, Intraventricular; Male; Morphine; Naloxone; Rabbits | 1979 |
Effect of neurohypophyseal hormones on morphine dependence.
Topics: Animals; Arginine Vasopressin; Humans; Morphine Dependence; Naloxone; Oxytocin; Peptides; Rats; Vasopressins | 1977 |
Prolyl-leucyl-glycinamide (PLG) facilitates morphine dependence.
Topics: Analgesia; Animals; Arginine Vasopressin; Body Temperature; Body Weight; Drug Synergism; Female; Humans; Morphine Dependence; Naloxone; Oligopeptides; Oxytocin; Rats; Structure-Activity Relationship; Vasopressins | 1976 |
Do opioid receptors participate in the regulation of atrial natriuretic peptide (ANP) secretion in hypertensive patients?
Topics: Adult; Aldosterone; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Female; Humans; Hypertension; Immersion; Male; Naloxone; Receptors, Opioid; Renin; Renin-Angiotensin System | 1992 |
[Effect of opioid receptor blockade with naloxone on vasopressin secretion in patients with transplanted kidney].
Topics: Adult; Arginine Vasopressin; Blood Pressure; Female; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Naloxone; Receptors, Opioid; Stimulation, Chemical | 1992 |
Participation of arginine vasopressin-mediated and adrenergic system-mediated mechanisms in the hypertension induced by intracerebroventricular administration of NMDA in freely moving rats.
Topics: 2-Amino-5-phosphonovalerate; Animals; Arginine Vasopressin; Blood Pressure; Cerebral Ventricles; Clonidine; Dose-Response Relationship, Drug; Epinephrine; Heart Rate; Hypertension; Injections, Intravenous; Injections, Intraventricular; Male; N-Methylaspartate; Naloxone; Norepinephrine; Prazosin; Rats; Rats, Inbred Strains | 1992 |
Intracellular calcium and hormone release from nerve endings of the neurohypophysis in the presence of opioid agonists and antagonists.
Topics: Animals; Arginine Vasopressin; Benzomorphans; Calcium; Cytoplasm; Diprenorphine; Dynorphins; Electric Stimulation; In Vitro Techniques; Male; Naloxone; Narcotic Antagonists; Narcotics; Nerve Endings; Oxytocin; Peptide Fragments; Pituitary Gland, Posterior; Potassium; Rats; Rats, Sprague-Dawley; Rats, Wistar | 1992 |
Further studies on the anti-nociceptive effect of vasopressin.
Topics: Analgesics; Animals; Arginine Vasopressin; Clonidine; Male; Mice; Naloxone; Yohimbine | 1992 |
Oxytocin and vasopressin release in discrete brain areas after naloxone in morphine-tolerant and -dependent anesthetized rats: push-pull perfusion study.
Topics: Anesthesia; Animals; Arginine Vasopressin; Brain; Drug Tolerance; Female; In Vitro Techniques; Morphine; Naloxone; Oxytocin; Perfusion; Pituitary Gland, Posterior; Radioimmunoassay; Rats; Rats, Inbred Strains; Substance-Related Disorders | 1992 |
Kappa-opioid modulation of vasopressin secretion in conscious rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Arginine Vasopressin; Cerebral Ventricles; Dose-Response Relationship, Drug; Drug Synergism; Injections, Intravenous; Male; Morphine; Naloxone; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Opioid; Sodium Chloride | 1991 |
Endogenous opioid mediation of somatostatin inhibition of arginine vasopressin release evoked by insulin-induced hypoglycemia in man.
Topics: Adult; Arginine Vasopressin; Endorphins; Humans; Hypoglycemia; Insulin; Male; Naloxone; Pituitary Gland, Posterior; Somatostatin | 1991 |
Centrally administered galanin inhibits osmotically stimulated arginine vasopressin release in conscious rats.
Topics: Animals; Arginine Vasopressin; Dose-Response Relationship, Drug; Galanin; Hypertonic Solutions; Injections, Intraventricular; Male; Naloxone; Osmolar Concentration; Peptides; Rats; Rats, Inbred Strains | 1991 |
Possible involvement of endogenous opioid peptides in the inhibition of arginine vasopressin release by gamma-aminobutyric acid in conscious rats.
Topics: Animals; Arginine Vasopressin; Dose-Response Relationship, Drug; Endorphins; gamma-Aminobutyric Acid; Injections, Intraventricular; Kinetics; Male; Naloxone; Rats; Rats, Inbred Strains; Saline Solution, Hypertonic | 1991 |
Naloxone increases the release of oxytocin, but not vasopressin, within limbic brain areas of conscious parturient rats: a push-pull perfusion study.
Topics: Animals; Arginine Vasopressin; Consciousness; Female; Labor, Obstetric; Limbic System; Naloxone; Oxytocin; Perfusion; Pregnancy; Rats; Rats, Inbred Strains; Time Factors; Tissue Distribution | 1991 |
Interaction of vasopressin and opioids during rapid hemorrhage in conscious rabbits.
Topics: Animals; Arginine Vasopressin; Drug Interactions; Endorphins; Hemodynamics; Hemorrhage; Hypotension; Naloxone; Narcotic Antagonists; Rabbits; Rest | 1991 |
Local control of Leydig cell arginine vasopressin receptor by naloxone.
Topics: Animals; Arginine Vasopressin; Kinetics; Leydig Cells; Male; Mice; Naloxone; Receptors, Angiotensin; Receptors, Vasopressin; Reference Values | 1991 |
Neurohumoral pathways mediating stress-induced inhibition of gastric acid secretion in rats.
Topics: Adrenal Glands; Animals; Arginine Vasopressin; Bretylium Tosylate; Chlorisondamine; Corticotropin-Releasing Hormone; Ganglia, Sympathetic; Gastric Acid; Male; Naloxone; Neural Pathways; Neurotransmitter Agents; Pentagastrin; Pituitary Gland; Rats; Rats, Inbred Strains; Stress, Physiological; Vagus Nerve | 1990 |
Naloxone increases the angiotensin II stimulated rise of arginine vasopressin and oxytocin secretion in man.
Topics: Adult; Angiotensin II; Arginine Vasopressin; Blood; Humans; Kinetics; Male; Naloxone; Osmolar Concentration; Oxytocin | 1991 |
Inhibitory effect of ethanol on the arginine vasopressin response to insulin-induced hypoglycemia and the role of endogenous opioids.
Topics: Adult; Arginine Vasopressin; Blood Glucose; Drug Interactions; Endorphins; Ethanol; Humans; Hypoglycemia; Insulin; Male; Naloxone | 1990 |
Kappa-opioid-receptor agonists modulate the renal excretion of water and electrolytes in anaesthetized rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Anesthesia; Animals; Arginine Vasopressin; Diabetes Insipidus; Electrolytes; Glomerular Filtration Rate; Male; Naloxone; Potassium; Pyrrolidines; Rats; Rats, Brattleboro; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa; Sodium | 1990 |
Effects of a [Met]-enkephalin analogue ( [D-Ala2,N-Me-Phe4,Met-(O)5-ol]-enkephalin) on canine pituitary function.
Topics: Adrenocorticotropic Hormone; alpha-MSH; Animals; Arginine Vasopressin; D-Ala(2),MePhe(4),Met(0)-ol-enkephalin; Dogs; Dose-Response Relationship, Drug; Female; Growth Hormone; Hydrocortisone; Male; Naloxone; Pituitary Gland; Prolactin; Stimulation, Chemical | 1990 |
Neurohypophysial secretion to insulin-induced hypoglycemia and its regulation by endogenous opioids in women.
Topics: Arginine Vasopressin; Endorphins; Female; Follicular Phase; Humans; Hypoglycemia; Insulin; Luteal Phase; Naloxone; Oxytocin; Pituitary Gland, Posterior; Sex Factors | 1990 |
Investigation of the mechanism by which insulin-induced hypoglycemia decreases luteinizing hormone secretion in ovariectomized ewes.
Topics: Animals; Arginine Vasopressin; Corticotropin-Releasing Hormone; Female; Glucose; Hydrocortisone; Hypoglycemia; Insulin; Kinetics; Luteinizing Hormone; Naloxone; Ovariectomy; Sheep | 1990 |
Phenylephrine-induced antinociception: investigations of potential neural and endocrine bases.
Topics: Adrenal Glands; Analgesics; Animals; Arginine Vasopressin; Blood Pressure; Corticosterone; Dexamethasone; Endocrine Glands; Heart Rate; Male; Monitoring, Physiologic; Naloxone; Naltrexone; Neural Pathways; Phenylephrine; Rats; Rats, Inbred Strains; Spinal Cord; Vasopressins | 1990 |
Neurohypophyseal hormones and excessive grooming behaviour.
Topics: Animals; Arginine Vasopressin; Benzazepines; Dose-Response Relationship, Drug; Grooming; Injections, Intraventricular; Injections, Subcutaneous; Male; Naloxone; Neurotensin; Oxymorphone; Oxytocin; Pituitary Hormones, Posterior; Rats; Rats, Inbred Strains | 1990 |
Increase by naloxone of arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia in obese men.
Topics: Adult; Arginine Vasopressin; Blood Pressure; Hematocrit; Humans; Hypoglycemia; Insulin; Male; Naloxone; Obesity; Osmolar Concentration; Oxytocin | 1990 |
Cerebroventricular calcitonin gene-related peptide inhibits rat duodenal bicarbonate secretion by release of norepinephrine and vasopressin.
Topics: Adrenalectomy; Animals; Arginine Vasopressin; Bicarbonates; Bretylium Compounds; Bretylium Tosylate; Calcitonin; Calcitonin Gene-Related Peptide; Cerebral Ventricles; Duodenum; Hypophysectomy; In Vitro Techniques; Injections, Intraventricular; Intestinal Mucosa; Male; Naloxone; Norepinephrine; Phentolamine; Rats; Rats, Inbred Strains; Reference Values; Vagotomy; Vasopressins | 1990 |
Vasopressin and stress-induced antinociception in the mouse.
Topics: Animals; Arginine Vasopressin; Behavior, Animal; Hot Temperature; Injections, Intraperitoneal; Injections, Intraventricular; Male; Mice; Mice, Inbred Strains; Naloxone; Nociceptors; Reaction Time; Stress, Psychological | 1990 |
The posterior pituitary contains a potent prolactin-releasing factor: in vivo studies.
Topics: Animals; Arginine Vasopressin; beta-Endorphin; Cell Extracts; Dose-Response Relationship, Drug; Female; Formates; Luteinizing Hormone; Naloxone; Ovariectomy; Oxidation-Reduction; Oxytocin; Pituitary Gland, Posterior; Rats; Rats, Inbred Strains; Thyrotropin-Releasing Hormone | 1989 |
Different gamma-aminobutyric acid receptor subtypes are involved in the regulation of opiate-dependent and independent luteinizing hormone-releasing hormone secretion.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Arginine Vasopressin; Baclofen; Bicuculline; Dinoprostone; gamma-Aminobutyric Acid; Gonadotropin-Releasing Hormone; Male; Median Eminence; Muscimol; Naloxone; Narcotics; Oxytocin; Phentolamine; Rats; Rats, Inbred Strains; Receptors, GABA-A | 1989 |
Evidence that intravenous morphine stimulates central opiate receptors to increase sympatho-adrenal outflow and cause hypertension in conscious rabbits.
Topics: Adrenalectomy; Animals; Arginine Vasopressin; Blood Pressure; Epinephrine; Heart Rate; Hypertension; Infusions, Intravenous; Injections, Intraventricular; Male; Morphine; Naloxone; Norepinephrine; Pentolinium Tartrate; Rabbits; Sympathetic Nervous System | 1989 |
Opioid-mediated inhibition of oxytocin during insulin-induced hypoglycemic stimulation of vasopressin in man.
Topics: Adult; Arginine Vasopressin; Humans; Hypoglycemia; Insulin; Male; Naloxone; Oxytocin; Receptors, Opioid | 1988 |
Volume-regulated arginine vasopressin release in conscious dogs. Evidence for dopaminergic or opioid modulation?
Topics: Animals; Arginine Vasopressin; Blood Pressure; Blood Volume; Bromocriptine; Dogs; Female; Heart Rate; Humans; Male; Naloxone; Receptors, Dopamine; Receptors, Opioid | 1988 |
Opioid-noradrenergic interactions in the neurohypophysis. II. Does noradrenaline mediate the actions of endogenous opioids on oxytocin and vasopressin release?
Topics: Animals; Arginine Vasopressin; Clonidine; Electric Stimulation; Endorphins; In Vitro Techniques; Isoproterenol; Male; Naloxone; Norepinephrine; Oxytocin; Pituitary Gland, Posterior; Rats; Receptors, Opioid; Yohimbine | 1988 |
Metergoline, naloxone, and sodium valproate did not modify arginine vasopressin response to insulin-induced hypoglycemia in man.
Topics: Adrenocorticotropic Hormone; Adult; Arginine Vasopressin; Ergolines; gamma-Aminobutyric Acid; Growth Hormone; Humans; Hypoglycemia; Insulin; Male; Metergoline; Naloxone; Valproic Acid | 1988 |
Effects of opioid agonists and antagonists on oxytocin and vasopressin release in vitro.
Topics: Animals; Arginine Vasopressin; Benzomorphans; beta-Endorphin; Cyclazocine; Dynorphins; Endorphins; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Ethylketocyclazocine; Male; Naloxone; Oxytocin; Peptide Fragments; Pituitary Gland, Posterior; Rats; Rats, Inbred Strains | 1985 |
Opioid binding in a rat neurohypophysial fraction enriched in oxytocin and vasopressin nerve endings.
Topics: Animals; Arginine Vasopressin; Binding Sites; Diprenorphine; Dynorphins; Endorphins; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Enkephalin, Methionine; Male; Naloxone; Oxytocin; Peptide Fragments; Pituitary Gland, Posterior; Rats | 1985 |
Naloxone affects the release of cortisol, but not of vasopressin or oxytocin, in dehydrated sheep.
Topics: Animals; Arginine Vasopressin; Female; Hydrocortisone; Naloxone; Osmolar Concentration; Ovariectomy; Oxytocin; Pituitary Gland; Sheep; Time Factors | 1989 |
Plasma arginine vasopressin response to intravenous methadone and naloxone in conscious dogs.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Dogs; Female; Heart Rate; Injections, Intravenous; Male; Methadone; Morphine; Naloxone | 1989 |
Central effect of the enkephalin analogue FK-33824 on vasopressin secretion in conscious sheep.
Topics: Animals; Arginine Vasopressin; D-Ala(2),MePhe(4),Met(0)-ol-enkephalin; Enkephalin, Methionine; Female; Infusions, Intravenous; Injections, Intraventricular; Naloxone; Sheep | 1989 |
The role of endorphins and vasopressin in canine endotoxin shock.
Topics: Animals; Arginine Vasopressin; beta-Endorphin; Blood Pressure; Cardiac Output; Cardiovascular Diseases; Dogs; Endorphins; Endotoxins; Escherichia coli; Female; Heart Rate; Hydrocortisone; Kinetics; Male; Naloxone; Shock, Septic | 1986 |
Plasma immunoreactive atrial natriuretic factor (IR-ANF) increases markedly after alpha 2-adrenergic stimulation with clonidine in normally-hydrated rats.
Topics: Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Clonidine; Dose-Response Relationship, Drug; Female; Kinetics; Naloxone; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Urine; Water-Electrolyte Balance | 1987 |
Pituitary secretions related to adrenocorticotropic hormone induce sensitivity of adipose tissue to the insulin-like actions of growth hormone.
Topics: Adipose Tissue; Adrenalectomy; Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Carbon Dioxide; Corticotropin-Releasing Hormone; Dexamethasone; Glucose; Growth Hormone; Insulin; Male; Naloxone; Oxidation-Reduction; Pituitary Gland; Pro-Opiomelanocortin; Rats | 1987 |
Effect of central naloxone on hormone and blood pressure responses to hemorrhage in conscious sheep.
Topics: Adrenocorticotropic Hormone; Aldosterone; Animals; Arginine Vasopressin; Blood Pressure; Cerebral Ventricles; Epinephrine; Female; Heart Rate; Hemorrhage; Hydrocortisone; Injections, Intraventricular; Kinetics; Naloxone; Norepinephrine; Sheep | 1987 |
Endogenous opioids inhibit oxytocin release during nicotine-stimulated secretion of vasopressin in man.
Topics: Adult; Arginine Vasopressin; Endorphins; Humans; Male; Naloxone; Nicotine; Oxytocin; Smoking | 1988 |
Effect of the opioid kappa-receptor agonist U50488H on the secretion of arginine vasopressin. Study on the mechanism of U50488H-induced diuresis.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Arginine Vasopressin; Dehydration; Diuresis; Injections, Subcutaneous; Male; Naloxone; Osmolar Concentration; Polyethylene Glycols; Pyrrolidines; Rats; Rats, Inbred Strains; Sodium | 1988 |
Inhibitory action of leumorphin on vasopressin secretion in conscious rats.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Brain; Carbachol; Dehydration; Enkephalins; Injections, Intraventricular; Male; Naloxone; Protein Precursors; Rats; Rats, Inbred Strains | 1988 |
Implication of leumorphin in inhibitory control of vasopressin secretion in conscious rats.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Consciousness; Enkephalins; Male; Naloxone; Protein Precursors; Rats | 1988 |
Effect of naloxone on oxytocin and vasopressin release during vaginocervical stimulation in the goat.
Topics: Animals; Arginine Vasopressin; Cervix Uteri; Female; Goats; Naloxone; Oxytocin; Physical Stimulation; Pituitary Gland, Posterior; Vagina | 1987 |
Cardiovascular effects of chronic naloxone infusion in normal dogs.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Cardiovascular System; Dogs; Epinephrine; Heart Rate; Male; Naloxone; Norepinephrine; Renin | 1986 |
Limbic oxytocin and arginine 8-vasopressin in morphine tolerance and dependence.
Topics: Amygdala; Animals; Arginine Vasopressin; Drug Tolerance; Hippocampus; Limbic System; Male; Mice; Mice, Inbred Strains; Morphine; Morphine Dependence; Naloxone; Oxytocin; Peptide Fragments; Radioimmunoassay | 1987 |
Naloxone decreases the inhibiting effect of ethanol on the release of arginine-vasopressin induced by cigarette smoking in man.
Topics: Adult; Arginine Vasopressin; Ethanol; Female; Humans; Male; Naloxone; Nicotine; Smoking | 1987 |
Temporal changes in the activity of endogenous opioid mechanisms regulating oxytocin secretion in saline-loaded rats.
Topics: Animals; Arginine Vasopressin; Biomechanical Phenomena; Endorphins; Female; Naloxone; Oxytocin; Rats; Rats, Inbred Strains; Sodium Chloride; Time Factors | 1987 |
Drinking and subsequent suppression of vasopressin is unaltered by naloxone in dogs.
Topics: Animals; Arginine Vasopressin; Dogs; Drinking Behavior; Endorphins; Naloxone; Water Deprivation | 1986 |
Inhibition of release of neurohypophysial hormones by endogenous opioid peptides in pregnant and parturient rats.
Topics: Animals; Arginine Vasopressin; Endorphins; Female; Hematocrit; Labor, Obstetric; Litter Size; Naloxone; Oxytocin; Pituitary Gland, Posterior; Pregnancy; Pregnancy, Animal; Radioimmunoassay; Rats | 1986 |
A sex difference in endogenous opioid regulation of the posterior pituitary response to stress in the rat.
Topics: Animals; Arginine Vasopressin; Endorphins; Female; Male; Morphine; Naloxone; Orchiectomy; Oxytocin; Pituitary Gland, Posterior; Rats; Rats, Inbred Strains; Restraint, Physical; Sex Characteristics; Stimulation, Chemical; Stress, Physiological | 1986 |
Corticotropin-releasing factor. Mechanisms to inhibit gastric acid secretion in conscious dogs.
Topics: Animals; Arginine Vasopressin; Autonomic Nervous System; Chlorisondamine; Corticotropin-Releasing Hormone; Dogs; Eating; Gastric Acid; Gastrins; Male; Naloxone; Pentagastrin; Vagotomy; Vasopressins | 1985 |
Evidence for a role of opioid peptides in the release of arginine vasopressin in the conscious rat.
Topics: Animals; Arginine Vasopressin; Consciousness; Dextrans; Endorphins; Kidney Concentrating Ability; Male; Morphinans; Naloxone; Narcotic Antagonists; Osmolar Concentration; Osmosis; Rats; Rats, Inbred Strains; Saline Solution, Hypertonic | 1982 |
Substance P-induced release of Met5-enkephalin from striatal and periaqueductal gray slices.
Topics: Animals; Arginine Vasopressin; Bombesin; Corpus Striatum; Dose-Response Relationship, Drug; Enkephalin, Methionine; Male; Naloxone; Neurotensin; Nociceptors; Peptide Fragments; Periaqueductal Gray; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; Sensory Thresholds; Substance P | 1983 |
Effect of ACTH and vasopressin on extinction: evidence of opiate mediation.
Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Avoidance Learning; Cosyntropin; Dose-Response Relationship, Drug; Extinction, Psychological; Male; Mental Recall; Morphine; Motivation; Naloxone; Rats; Reaction Time; Receptors, Opioid | 1984 |
Release of vasopressin in response to hypoxia and the effect of aminergic and opioid antagonists.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Guanethidine; Heart Rate; Hypoxia; Levallorphan; Male; Metoclopramide; Naloxone; Narcotic Antagonists; Phenoxybenzamine; Phentolamine; Propranolol; Rats; Rats, Inbred Strains; Sympatholytics | 1983 |
The effect of fentanyl on arginine vasopressin and cortisol secretion during anesthesia.
Topics: Adult; Anesthesia; Arginine Vasopressin; Female; Fentanyl; Halothane; Humans; Hydrocortisone; Naloxone | 1984 |
Opioid and dopamine involvement in prolactin release induced by arginine vasotocin and vasopressin in the male rat.
Topics: Animals; Apomorphine; Arginine Vasopressin; Dopamine; Endorphins; Hypothalamo-Hypophyseal System; Male; Methysergide; Naloxone; Prolactin; Rats; Rats, Inbred Strains; Vasopressins | 1984 |
Blood pressure and vasopressin in progressive autonomic failure. Response to postural stimulation, L-dopa and naloxone.
Topics: Aged; Arginine Vasopressin; Autonomic Nervous System Diseases; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Naloxone; Physical Stimulation; Posture | 1983 |
Vasopressin-induced antinociception: an investigation into its physiological and hormonal basis.
Topics: Animals; Arginine Vasopressin; Deamino Arginine Vasopressin; Dose-Response Relationship, Drug; Hypophysectomy; Lypressin; Male; Morphine; Naloxone; Nociceptors; Rats; Vasopressins | 1983 |
Naltrexone effects on plasma vasopressin concentration elevated and lowered by various stimuli.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Hematocrit; Male; Naloxone; Naltrexone; Nicotine; Rats; Rats, Inbred Strains; Sodium; Stress, Physiological; Water-Electrolyte Balance | 1983 |
Evidence for endogenous opioid control of vasopressin release in man.
Topics: Adult; Arginine Vasopressin; Endorphins; Female; Humans; Male; Naloxone | 1980 |
Effects of the opiate antagonist naloxone and the enkephalin analog DAMME on the vasopressin response to a hypertonic stimulus in man.
Topics: Adult; Arginine Vasopressin; D-Ala(2),MePhe(4),Met(0)-ol-enkephalin; Endorphins; Enkephalins; Humans; Kidney; Male; Naloxone; Osmolar Concentration; Saline Solution, Hypertonic; Sodium; Sodium Chloride | 1980 |
Increased pressor responsiveness to enkephalin in spontaneously hypertensive rats: the role of vasopressin.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Endorphins; Enkephalins; Female; Heart Rate; Hypertension; Injections, Intraventricular; Male; Naloxone; Rats; Stimulation, Chemical | 1980 |
Cardiovascular responses to cigarette smoke exposure in restrained conscious rats.
Topics: Animals; Arginine Vasopressin; Atropine; Blood Pressure; Heart Rate; Lidocaine; Male; Muscarinic Antagonists; Naloxone; Nicotine; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Receptors, Opioid; Restraint, Physical; Smoking; Stress, Psychological | 1995 |
The effect of naloxone administration on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin in unperturbed horses.
Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Corticotropin-Releasing Hormone; Dose-Response Relationship, Drug; Female; Horses; Hydrocortisone; Kinetics; Naloxone; Pituitary Gland; Veins | 1995 |
Stimulus-induced depletion of pro-enkephalins, oxytocin and vasopressin and pro-enkephalin interaction with posterior pituitary hormone release in vitro.
Topics: Animals; Arginine Vasopressin; Cytoplasmic Granules; Dynorphins; Electric Stimulation; Enkephalin, Methionine; Female; Male; Morphine; Morphine Dependence; Naloxone; Organ Culture Techniques; Oxytocin; Pituitary Gland, Posterior; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1994 |
Naloxone disinhibits magnocellular responses to osmotic and volemic stimuli in chronically hypoosmolar rats.
Topics: Animals; Arginine Vasopressin; Cerebral Hemorrhage; Hypothalamus; Isotonic Solutions; Male; Naloxone; Osmolar Concentration; Oxytocin; Rats; Rats, Sprague-Dawley; Sodium; Sodium Chloride; Water-Electrolyte Imbalance | 1995 |
Elevated basal adrenocorticotropin and evidence for increased central opioid tone in highly trained male athletes.
Topics: Adrenocorticotropic Hormone; Adult; Arginine Vasopressin; Brain; Corticotropin-Releasing Hormone; Endorphins; Humans; Hydrocortisone; Male; Naloxone; Physical Education and Training; Sports | 1995 |
Dynorphin-A and vasopressin release in the rat: a structure-activity study.
Topics: Analysis of Variance; Animals; Arginine Vasopressin; Cerebral Ventricles; Dynorphins; Immune Sera; In Vitro Techniques; Injections, Intraventricular; Male; Naloxone; Peptide Fragments; Pituitary Gland, Posterior; Radioimmunoassay; Rats; Rats, Wistar; Structure-Activity Relationship; Time Factors | 1994 |
Vasopressin-induced changes in cardiac vagal tone and oxygen consumption in dogs.
Topics: Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Cardiac Pacing, Artificial; Denervation; Dogs; Heart Conduction System; Male; Naloxone; Oxygen Consumption; Oxytocin; Pilocarpine; Reference Values; Sinus of Valsalva; Vagotomy; Vagus Nerve | 1994 |
Role of GABA and opioids in the regulation of the vasopressin response to physical exercise in normal men.
Topics: Adult; Arginine Vasopressin; Cardiovascular Physiological Phenomena; Endorphins; Exercise; gamma-Aminobutyric Acid; Humans; Male; Naloxone; Respiration; Valproic Acid | 1993 |
Effects of argipressin injected into medial amygdaloid body on blood pressure and heart rate in rats.
Topics: Amygdala; Animals; Arginine Vasopressin; Blood Pressure; Female; Heart Rate; Male; Microinjections; Naloxone; Rats; Rats, Wistar | 1993 |
Local regulation of testicular immunoreactive-arginine vasopressin and steroidogenesis by naloxone.
Topics: Animals; Arginine Vasopressin; Chorionic Gonadotropin; Dose-Response Relationship, Drug; In Vitro Techniques; Leydig Cells; Male; Mice; Naloxone; Testis; Testosterone | 1993 |
Gamma-aminobutyric acid mediation of the inhibitory effect of endogenous opioids on the arginine vasopressin and oxytocin responses to nicotine from cigarette smoking.
Topics: Adult; Analysis of Variance; Arginine Vasopressin; Drug Interactions; Endorphins; gamma-Aminobutyric Acid; Humans; Male; Naloxone; Nicotine; Oxytocin; Smoking; Valproic Acid | 1993 |
Plasma levels of beta-endorphin, leucine enkephalin and arginine vasopressin in patients with essential hypertension and the effects of clonidine.
Topics: Angiotensin II; Antihypertensive Agents; Arginine Vasopressin; beta-Endorphin; Blood Pressure; Clonidine; Enkephalin, Leucine; Female; Heart Rate; Humans; Hypertension; Injections, Intravenous; Male; Middle Aged; Naloxone; Narcotic Antagonists; Neurotensin; Renin; Time Factors | 1995 |
Centrally administered neuropeptide FF inhibits arginine vasopressin release in conscious rats.
Topics: Amino Acid Sequence; Animals; Arginine Vasopressin; Blood Volume; Brain Stem; Hypothalamus; Kinetics; Male; Molecular Sequence Data; Naloxone; Oligopeptides; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Saline Solution, Hypertonic; Solitary Nucleus; Water-Electrolyte Balance | 1996 |
kappa-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenocorticotropic Hormone; Analgesics; Animals; Arginine Vasopressin; Corticotropin-Releasing Hormone; Female; Hydrocortisone; Hypothalamus; Naloxone; Pituitary-Adrenal System; Pregnancy; Pyrrolidines; Receptors, Opioid, kappa; Sheep | 1996 |
The luteinizing hormone but not the cortisol response to arginine vasopressin is prevented by naloxone and a corticotropin-releasing hormone antagonist in the ovariectomized rhesus monkey.
Topics: Adrenal Glands; Animals; Arginine Vasopressin; Corticotropin-Releasing Hormone; Female; Hydrocortisone; Luteinizing Hormone; Macaca mulatta; Naloxone; Ovariectomy; Ovary; Stimulation, Chemical | 1996 |
Dynorphin A1-13 stimulates ovine fetal pituitary-adrenal function through a novel nonopioid mechanism.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Corticotropin-Releasing Hormone; Dynorphins; Female; Fetus; Hydrocortisone; Hypothalamo-Hypophyseal System; Naloxone; Peptide Fragments; Pituitary-Adrenal System; Pregnancy; Pyrrolidines; Sheep | 1997 |
Inherent glucocorticoid response potential of isolated hypothalamic neuroendocrine neurons.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Arginine Vasopressin; beta-Endorphin; Calcium; Cells, Cultured; Coculture Techniques; Corticotropin-Releasing Hormone; Culture Media, Serum-Free; Dexamethasone; Glucocorticoids; Kinetics; Male; Mifepristone; Morphine; Naloxone; Neurons; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Sodium; Tetrodotoxin; Verapamil; Veratridine | 1998 |
Attenuation of cryogenic induced brain oedema by arginine vasopressin release inhibitor RU51599.
Topics: Animals; Arginine Vasopressin; Benzeneacetamides; Blood-Brain Barrier; Brain Chemistry; Brain Edema; Brain Injuries; Cold Temperature; Diuretics; Evans Blue; Male; Naloxone; Potassium; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa; Sodium; Spectrophotometry, Atomic | 1997 |
Interaction of opioids and vasopressin in central action of angiotensin II in conscious rabbits.
Topics: Angiotensin II; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Cardiovascular System; Consciousness; Dose-Response Relationship, Drug; Drug Interactions; Epinephrine; Heart Rate; Hormone Antagonists; Injections, Intraventricular; Male; Naloxone; Narcotic Antagonists; Narcotics; Rabbits; Sympathetic Nervous System; Vasoconstrictor Agents; Vasopressins | 1998 |
Microinjection of arginine vasopressin into the central nucleus of amygdala suppressed nociceptive jaw opening reflex in freely moving rats.
Topics: Adrenergic alpha-Antagonists; Amygdala; Animals; Arginine Vasopressin; Dose-Response Relationship, Drug; Electric Stimulation; Electromyography; Male; Masticatory Muscles; Methysergide; Microinjections; Movement; Muscle Contraction; Naloxone; Narcotic Antagonists; Neurons; Nociceptors; Pain; Pain Measurement; Phentolamine; Rats; Rats, Sprague-Dawley; Reflex; Serotonin Antagonists | 2001 |
Hypoglycemia-induced suppression of luteinizing hormone (LH) secretion in intact female rhesus macaques: role of vasopressin and endogenous opioids.
Topics: Animals; Arginine Vasopressin; Blood Glucose; Corticotropin-Releasing Hormone; Endorphins; Female; Hydrocortisone; Hypoglycemia; Hypoglycemic Agents; Insulin; Luteinizing Hormone; Macaca mulatta; Menstrual Cycle; Naloxone; Narcotic Antagonists; Vasopressins | 2002 |
Centrally administered tuberoinfundibular peptide of 39 residues inhibits arginine vasopressin release in conscious rats.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Consciousness; Dehydration; Dose-Response Relationship, Drug; Hypothalamo-Hypophyseal System; Hypovolemia; Injections, Intraventricular; Male; Naloxone; Narcotic Antagonists; Neuropeptides; Rats; Rats, Sprague-Dawley; Water-Electrolyte Balance | 2003 |
Effects of centrally administered vasopressin on orofacial pain perception in rats.
Topics: Analysis of Variance; Animals; Arginine Vasopressin; Brain Stem; Dental Pulp; Electric Stimulation; Hypoglossal Nerve; Injections, Intraventricular; Male; Methysergide; Naloxone; Narcotic Antagonists; Pain Threshold; Rats; Rats, Long-Evans; Serotonin Antagonists; Tongue; Trigeminal Nuclei | 2005 |
Amygdalar vasopressin mRNA increases in acute cocaine withdrawal: evidence for opioid receptor modulation.
Topics: Amygdala; Animals; Arginine Vasopressin; Cocaine; Dopamine Uptake Inhibitors; Gene Expression; Hypothalamo-Hypophyseal System; Hypothalamus; Male; Naloxone; Narcotic Antagonists; Pituitary-Adrenal System; Pro-Opiomelanocortin; Rats; Rats, Inbred F344; Receptors, Opioid, mu; RNA, Messenger; Substance Withdrawal Syndrome | 2005 |
Through central arginine vasopressin, not oxytocin and endogenous opiate peptides, glutamate sodium induces hypothalamic paraventricular nucleus enhancing acupuncture analgesia in the rat.
Topics: Acupuncture Analgesia; Animals; Arginine Vasopressin; Dynorphins; Electroacupuncture; Enkephalin, Leucine; Glutamic Acid; Injections, Intraventricular; Male; Microinjections; Naloxone; Narcotic Antagonists; Neurons; Opioid Peptides; Oxytocin; Pain Threshold; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Rats; Rats, Sprague-Dawley | 2006 |
Activation of central opioid receptors determines the timing of hypotension during acute hemorrhage-induced hypovolemia in conscious sheep.
Topics: Acute Disease; Analgesics, Opioid; Animals; Arginine Vasopressin; Blood Pressure; Central Venous Pressure; Consciousness; Dose-Response Relationship, Drug; Female; Heart Rate; Hemorrhage; Hypotension; Hypovolemia; Injections, Intraventricular; Morphine; Naloxone; Narcotic Antagonists; Receptors, Opioid; Recovery of Function; Renin; Sheep; Species Specificity; Vascular Resistance | 2006 |
Through V2, not V1 receptor relating to endogenous opiate peptides, arginine vasopressin in periaqueductal gray regulates antinociception in the rat.
Topics: Analgesics; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Male; Microinjections; Naloxone; Nociceptors; Opioid Peptides; Pain Threshold; Periaqueductal Gray; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin | 2006 |
Effect of naloxone on somatostatin inhibition of arginine vasopressin response to physical exercise in normal men.
Topics: Adult; Arginine Vasopressin; Blood Glucose; Drug Interactions; Exercise; Exercise Test; Humans; Male; Naloxone; Narcotic Antagonists; Opioid Peptides; Osmolar Concentration; Physical Fitness; Somatostatin; Up-Regulation | 2008 |
Effect of arginine vasopressin on acupuncture analgesia in the rat.
Topics: Acupuncture Analgesia; Animals; Arginine Vasopressin; Male; Naloxone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley | 2009 |
Effect of naloxone on the inhibitory effect of melatonin on the release of arginine-vasopressin induced by physical exercise in man.
Topics: Arginine Vasopressin; Drug Interactions; Exercise; Humans; Male; Melatonin; Naloxone; Radioimmunoassay | 2010 |
[Effects of naloxone on the contents of cAMP in hypothalamus and AVP in ventral septal area in fever rats].
Topics: Animals; Arginine Vasopressin; Cyclic AMP; Fever; Hypothalamus; Male; Naloxone; Rats; Rats, Sprague-Dawley; Septum of Brain | 2009 |